drugset / Trial / NCT02815657
The Drug-drug Interaction of SP2086 and Valsartan
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to investigate the potential interaction between SP2086 and Valsartan after multiple oral doses treatment in healthy adult volunteers.
Timeline
- Start
- 2013-04
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Retagliptin | Small molecule | 200 mg | Oral |
| Comparator | Valsartan | Small molecule | 160 mg | — |